| NDC Code | 17312-021-14 |
| Package Description | 1 BOTTLE in 1 PACKAGE (17312-021-14) / 70 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE |
| Product NDC | 17312-021 |
| Product Type Name | HUMAN OTC DRUG |
| Proprietary Name | Sciatica Therapy |
| Non-Proprietary Name | Arnica Montana - Citrullus Colocynthis Fruit Pulp - Pseudognaphalium Obtusifolium - Hypericum Perforatum - Potassium Iodide - Magnesium Phosphate, Dibasic Trihydrate - Toxicodendron Pubescens Leaf - |
| Dosage Form | TABLET, ORALLY DISINTEGRATING |
| Usage | ORAL |
| Start Marketing Date | 20111201 |
| Marketing Category Name | UNAPPROVED HOMEOPATHIC |
| Manufacturer | TRP Company |
| Substance Name | ARNICA MONTANA; CITRULLUS COLOCYNTHIS FRUIT PULP; HYPERICUM PERFORATUM; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; POTASSIUM IODIDE; PSEUDOGNAPHALIUM OBTUSIFOLIUM; TOXICODENDRON PUBESCENS LEAF |
| Strength | 6; 6; 6; 6; 6; 6; 6 |
| Strength Unit | [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1 |
| Pharmacy Classes | Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE] |